Related Experiment Videos

Prevention of death in Semliki Forest virus-infected mice by administration of defective-interfering Semliki Forest

Insights

Intranasal administration of defective-interfering Semliki Forest virus (DI SFV) protected adult mice from lethal central nervous system infection. This protection was linked to the DI virus's inherent interfering capacity.

Area of Science:

  • Virology
  • Neuroscience
  • Immunology

Background:

  • Semliki Forest virus (SFV) causes lethal central nervous system infections.
  • Defective-interfering (DI) viral particles possess the ability to interfere with the replication of standard viruses.

Purpose of the Study:

  • To investigate the protective potential of intranasally administered defective-interfering Semliki Forest virus (DI SFV) against lethal SFV infection in the central nervous system.
  • To elucidate the mechanism of protection conferred by DI SFV.

Main Methods:

  • Adult mice were inoculated with a lethal dose of SFV.
  • Mice received intranasal administration of u.v.-irradiated, unpurified DI SFV.
  • DI SFV was prepared through high multiplicity of infection (m.o.i.) passages in BHK 21 cells.
  • Viral replication in the brain was quantified.

Main Results:

  • Intranasal administration of DI SFV significantly protected mice from lethal SFV-induced central nervous system infection.
  • Protection was maximal when DI SFV was administered concurrently with the infecting SFV inoculum.
  • A 10(5)-fold reduction in infective virus multiplication was observed in the brains of treated mice.
  • DI SFV was shown to propagate within the mouse brain following intranasal inoculation.

Conclusions:

  • Intranasal administration of DI SFV provides effective protection against lethal SFV encephalitis.
  • The protective effect is attributed to the intrinsic viral interference mechanism of DI SFV.
  • DI SFV can replicate in the brain, contributing to its therapeutic efficacy.

Related Concept Videos